郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

心血管疾病Identification and Structure-Activity Relationship (SAR) of potent and selective oxadiazole-based agonists of sphingosine-1-phosphate receptor (S1P1).

期刊：Bioorganic chemistry发表年份：2019作者：Tianqi Liu; Jing Jin; Yonghui Chen; Qiumu Xi; Jinping Hu; Wenqiang Jia; Xiaoguang Chen; Yan Li; Xiaojian Wang; Dali Yin
阅读更多 →

心血管疾病Structure of the lipoprotein lipase-GPIHBP1 complex that mediates plasma triglyceride hydrolysis.

期刊：Proceedings of the National Academy of Sciences of the United States of America发表年份：2019作者：Gabriel Birrane; Anne P Beigneux; Brian Dwyer; Bettina Strack-Logue; Kristian Kølby Kristensen; Omar L Francone; Loren G Fong; Haydyn D T Mertens; Clark Q Pan; Michael Ploug; Stephen G Young; Muthuraman Meiyappan
阅读更多 →

心血管疾病Acute toxicity and genotoxicity evaluations of Nattokinase, a promising agent for cardiovascular diseases prevention.

期刊：Regulatory toxicology and pharmacology : RTP发表年份：2019作者：Hao Wu; Huan Wang; Feng Xu; Jiepeng Chen; Lili Duan; Fengjiao Zhang
阅读更多 →

心血管疾病Pharmacological Characterization of a Novel 5-Hydroxybenzothiazolone-Derived β 2-Adrenoceptor Agonist with Functional Selectivity for Anabolic Effects on Skeletal Muscle Resulting in a Wider Cardiovascular Safety Window in Preclinical Studies.

期刊：The Journal of pharmacology and experimental therapeutics发表年份：2019作者：Magdalena Koziczak-Holbro; Dean F Rigel; Bérengère Dumotier; David A Sykes; Jeffrey Tsao; Ngoc-Hong Nguyen; Julian Bösch; Marie Jourdain; Ludivine Flotte; Yuichiro Adachi; Michael Kiffe; Moïse Azria; Robin A Fairhurst; Steven J Charlton; Brian P Rich
阅读更多 →